Literature DB >> 15475264

Genetic mapping of a Ptch1-associated rhabdomyosarcoma susceptibility locus on mouse chromosome 2.

Heidi Hahn1, Frauke Nitzki, Tatjana Schorban, Bernhard Hemmerlein, David Threadgill, Michael Rosemann.   

Abstract

Mutations in the Patched (Ptch1) gene are responsible for various familial and sporadic cancers. Ptch1(neo67/+) mice, in which exons 6 and 7 are deleted, show genetic background-dependent susceptibility to the development of muscle tumors resembling human rhabdomyosarcoma (RMS); BALB/c (BALB) is a susceptible strain whereas C57BL/6 (B6) shows resistance. A genome-wide linkage analysis was carried out using Ptch1(neo67/+)mice produced from B6 x (BALB x B6) backcrosses to identify loci involved in the control of RMS susceptibility. Quantitative trait locus mapping with the censored tumor latency time as the quantitative parameter was used to detect a significant RMS susceptibility modifier locus, Parms1 (Patched-Associated RMS 1), on chromosome 2 between D2Mit37 and D2Mit102 (LRS = 10). A Kaplan-Meier survival curve revealed that mice with the B6/BALB genotype develop tumors more frequently and much faster as compared to mice homozygous for the B6 allele (P = 0.02). Additional loci not reaching linkage significance were also detected for medulloblastoma resistance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475264     DOI: 10.1016/j.ygeno.2004.07.002

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  13 in total

1.  Quantitative trait locus analysis identifies rat genomic regions related to amphetamine-induced locomotion and Galpha(i3) levels in nucleus accumbens.

Authors:  Marc N Potenza; Edward S Brodkin; Bao-Zhu Yang; Shari G Birnbaum; Eric J Nestler; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2008-01-23       Impact factor: 7.853

Review 2.  The Hedgehog's tale: developing strategies for targeting cancer.

Authors:  Jessica M Y Ng; Tom Curran
Journal:  Nat Rev Cancer       Date:  2011-05-26       Impact factor: 60.716

3.  Clinical and mutational spectrum of highly differentiated, paired box 3:forkhead box protein o1 fusion-negative rhabdomyosarcoma: A report from the Children's Oncology Group.

Authors:  Lisa A Teot; Michaela Schneider; Aaron R Thorner; Jing Tian; Yueh-Yun Chi; Matthew Ducar; Ling Lin; Marcin Wlodarski; Holcombe E Grier; Christopher D M Fletcher; Paul van Hummelen; Stephen X Skapek; Douglas S Hawkins; Amy J Wagers; Carlos Rodriguez-Galindo; Simone Hettmer
Journal:  Cancer       Date:  2018-02-20       Impact factor: 6.860

4.  Hedgehog/Patched-associated rhabdomyosarcoma formation from delta1-expressing mesodermal cells.

Authors:  F Nitzki; N Cuvelier; J Dräger; A Schneider; T Braun; H Hahn
Journal:  Oncogene       Date:  2015-09-21       Impact factor: 9.867

5.  DNA damage, somatic aneuploidy, and malignant sarcoma susceptibility in muscular dystrophies.

Authors:  Wolfgang M Schmidt; Mohammed H Uddin; Sandra Dysek; Karin Moser-Thier; Christine Pirker; Harald Höger; Inge M Ambros; Peter F Ambros; Walter Berger; Reginald E Bittner
Journal:  PLoS Genet       Date:  2011-04-14       Impact factor: 5.917

6.  Physeal bystander effects in rhabdomyosarcoma radiotherapy: experiments in a new xenograft model.

Authors:  Jason A Horton; Judith A Strauss; Matthew J Allen; Timothy A Damron
Journal:  Sarcoma       Date:  2011-04-17

7.  Embryonic signaling pathways and rhabdomyosarcoma: contributions to cancer development and opportunities for therapeutic targeting.

Authors:  Brian Belyea; Julie Grondin Kephart; Jordan Blum; David G Kirsch; Corinne M Linardic
Journal:  Sarcoma       Date:  2012-04-30

8.  Calcitriol inhibits hedgehog signaling and induces vitamin d receptor signaling and differentiation in the patched mouse model of embryonal rhabdomyosarcoma.

Authors:  Anja Uhmann; Hannah Niemann; Bérénice Lammering; Cornelia Henkel; Ina Heß; Albert Rosenberger; Christian Dullin; Anke Schraepler; Walter Schulz-Schaeffer; Heidi Hahn
Journal:  Sarcoma       Date:  2012-02-21

9.  Overexpression of mutant Ptch in rhabdomyosarcomas is associated with promoter hypomethylation and increased Gli1 and H3K4me3 occupancy.

Authors:  Frauke Nitzki; Ezequiel J Tolosa; Nicole Cuvelier; Anke Frommhold; Gabriela Salinas-Riester; Steven A Johnsen; Martin E Fernandez-Zapico; Heidi Hahn
Journal:  Oncotarget       Date:  2015-04-20

10.  CDO, an Hh-coreceptor, mediates lung cancer cell proliferation and tumorigenicity through Hedgehog signaling.

Authors:  Young-Eun Leem; Hye-Lim Ha; Ju-Hyeon Bae; Kwan-Hyuck Baek; Jong-Sun Kang
Journal:  PLoS One       Date:  2014-11-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.